Biopharmaceutical development first topic in series
The Centre for Health and Biotech Management Research (CHBMR) and Three Oaks Innovation Inc. will present Dr. Peter Smith of Millennium Pharmaceuticals on June 18, as the first instalment of the Innovation PEI Premier's Speaker Series.
As Senior Vice President, Drug Safety & Disposition and Comparative Medicine for Millennium Pharmaceuticals, Dr. Smith will provide insight into modern development approaches and strategies that efficiently promote drug candidates and biologics through the development process, which includes an overview of the research and corporate requirements to fulfill current registration requests of health authorities, both from a safety and non-clinical aspect.
Dr. Smith holds a Ph.D. in Pharmacology and Toxicology from the University of Arizona, and trained as a post-doctoral fellow in biochemical toxicology at SmithKline and French labs. Dr. Smith has served on several editorial boards including Toxicology Sciences, Journal of Pharmacological and Toxicological Methods, and Preclinica, and he has also served as an ad hoc reviewer for Toxicology and Applied Pharmacology and In Vitro Toxicology. Dr. Smith was featured in the July/August 2009 issue ofPharmaVOICE as one of the magazine's Top 100. The PharmaVOICE Top 100 is an annual feature ranking the 100 most inspiring individuals in the pharmaceutical and biotechnology industries.
Friday, June 18, 2010
Presentation, 10:00 - 11:30 a.m.
K.C. Irving Chemistry Centre, Room 104
Networking luncheon, 11:30 a.m. - 12:30 p.m.
Schurman Market Square, McDougall Hall
To register, click .
About the Innovation PEI Premier's Speaker Series at 秀色短视频
Dr. Juergen Krause, Associate Professor at 秀色短视频's School of Business and Director for the Centre for Health and Biotech Management Research (CHBMR), has been selected to organize and promote the Innovation PEI Premier's Speaker Series.
The series, aimed at enhancing knowledge in bioscience and forging international relationships for Island companies, will feature presentations in the upcoming weeks by three experts with experience in the areas of intellectual property, licensing technology, and research and development. For more information, visit .
